Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
32.27
-0.74 (-2.26%)
At close: Jun 9, 2025, 4:00 PM
33.30
+1.03 (3.21%)
After-hours: Jun 9, 2025, 7:25 PM EDT
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 437 employees as of December 31, 2024. The number of employees increased by 147 or 50.69% compared to the previous year.
Employees
437
Change (1Y)
147
Growth (1Y)
50.69%
Revenue / Employee
$1,739
Profits / Employee
-$751,149
Market Cap
3.02B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CRNX News
- 17 days ago - Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025 - GlobeNewsWire
- 25 days ago - Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025 - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals, Inc (CRNX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Crinetics Pharma: Strong Progress With Multiple Indications And Upcoming PDUFA - Seeking Alpha